Press release

Siemens Healthineers and Prisma Health Join Forces to Innovate Healthcare for South Carolina

Published on June 22, 2021

  • 10-year Value Partnership includes innovative technologies and an Intelligence Insights Center to aid in the prevention, diagnosis and treatment of diseases.

Siemens Healthineers and Prisma Health announced today a 10-year strategic relationship to help create a better state of health for South Carolina. This Value Partnership is focused on healthcare innovation, workforce development, and improving health care for patients and communities served by Prisma Health. Through this relationship, Siemens Healthineers and Prisma Health will deploy the latest generation of medical technology at all Prisma Health sites, collaborate to improve the delivery of clinical services, and form an Intelligence Insights Center with the goal of advancing healthcare.

Through the "Value Partnership" partnership model, hospitals can optimize business processes, expand capabilities and drive innovation. These partnerships rely on the entire Siemens Healthineers portfolio to create added value beyond equipment.

“We are excited to announce this innovative, long-term relationship to enhance quality and create even more value for our patients, and support our excellent team members and physicians in providing the best patient care and service possible,” said Mark O’Halla, President and Chief Executive Officer of Prisma Health. “Working together brings breakthrough opportunities to enhance clinical care through the latest clinical technology, streamlining our clinical and business processes, and bringing new advances in disease prevention, early diagnosis and treatment. This is especially important as we transition more and more towards value-based healthcare, where a health company such as Prisma Health is responsible for partnership with people to stay healthy, as opposed to caring for patients only when they are sick. We will continue to make significant strides forward in this direction through this important strategic relationship.“

“By joining forces, Siemens Healthineers and Prisma Health will now have the ability to expand and enhance the quality of healthcare available to the community,” said David Pacitti, President and Head of the Americas, Siemens Healthineers. “This long-term Value Partnership with Prisma Health is our company’s largest in the United States and represents the collective power of our two organizations and our shared vision of improving patient care.”

In recognition of these shared interests, the two organizations are forming the Intelligence Insights Center. The primary goal of the Center is to further enable Prisma Health to leverage its patient data via computerized algorithms, also known as artificial intelligence (AI), to enable physicians to make more informed clinical decisions – ultimately allowing for faster and more precise diagnoses and treatment plans – as well as to help predict or prevent disease. The deployment of innovative solutions in conjunction with related research initiatives aim to forge new ground in patient care, while simultaneously measuring the value of diagnostic testing, care and treatments. A second initiative will evaluate the potential of computer-aided workflow tools to increase best practices of care and reduce time-consuming operational tasks, allowing providers to spend more time in patient interactions.

Financial terms were not disclosed.

Download the image

Siemens Healthineers 2021

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion. Following the acquisition of Varian Medical Systems, Inc. the company has approximately 66,000 employees worldwide. Further information is available at www.siemens-healthineers.com.